By Devika Patel
Knoxville, Tenn., May 9 - Northwest Biotherapeutics, Inc. said it has arranged a $4 million loan agreement with Al Rajhi Holdings WLL.
The six-month loan is evidenced by a promissory note for $4.24 million, which equals an original issue discount of 6%.
Al Rajhi may elect to have the original issue discount amount paid at maturity in common stock.
Northwest is a development stage biotechnology company based in Bothell, Wash.
| Issuer: | Northwest Biotherapeutics, Inc.
|
| Issue: | Loan
|
| Amount: | $4.24 million
|
| Maturity: | Six months
|
| Price: | 94
|
| Warrants: | No
|
| Investor: | Al Rajhi Holdings WLL
|
| Pricing date: | May 9
|
| Stock symbol: | OTCBB: NWBO
|
| Stock price: | $2.00 at close May 8
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
